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Abstract
Adipose tissue contain progenitor cells with regenerative (angiogenic, neuroprotection, trophic
etc.)  potential  and  treatment  based  on  adipose  tissue-derived  stem  cells  (ADSCs)
transplantation may constitute a promising therapy. Genetic modification of stem cells with
genes encoding growth factors and other biologically active molecules might further increase
therapeutic efficiency. However, there is a question about the advantages and disadvantages of
such  gene/stem cell  therapy.  For  a  better  understanding  of  the  mechanisms occurring  in
organism after cell transplantation we should first study cell behavior in vitro. Here we report
results of ADSCs transfection with plasmid DNA pEGFP-N2 and subsequent study of cytokines
and  chemokines  secretion  using  Luminex  technology.  We  demonstrated  that  genetic
modification of ADSCs with commonly used control plasmid vector, encoding enhanced green
fluorescent protein (EGFP), did not affect secretion of cytokines/chemokines IFN-{filled circle},
IL-1{filled circle}, IL-2, IL-8, IL-10, IL-12, MCP-1. Thus, genetic modification procedure on its own
might have little effect on stem cell properties, making it useful for gene-stem cell therapy
applications. © IDOSI Publications, 2013.
http://dx.doi.org/10.5829/idosi.wasj.2013.26.07.13539
Keywords
Chemokines, Cytokines, Human Adipose Derived Stem Cells, pEGFP-N2, Plasmid, Transfection
